Publications by authors named "N M Hashish"
Article Synopsis
- Valproic acid (VPA) is a widely used drug for epilepsy but can lead to liver damage with long-term use.
- Liraglutide, an antidiabetic medication with anti-inflammatory properties, was tested for its potential to protect the liver from damage caused by VPA in a study involving rats.
- Results showed that liraglutide effectively reduced liver enzyme levels and markers of oxidative stress and inflammation, suggesting it can help mitigate VPA-induced liver damage.
Objective: To evaluate the effectiveness of the addition of growth hormone (GH) to the antagonist protocol in IVF/intracytoplasmic sperm injection cycles in poor responders.
Design: Parallel randomized, controlled, open-label trial.
Setting: University hospital.
Objective: To assess the efficacy of adding growth hormone (GH) to the microflare stimulation protocol among women with poor ovarian response.
Methods: A parallel, open-label, randomized controlled trial was conducted among patients with poor ovarian response who attended a center in Cairo, Egypt, between July 10 and December 31, 2014. Participants were randomly assigned using a computer program (random block size of 4-8) to undergo the microflare protocol with or without GH.
Background: To our knowledge, no large population - based studies have been performed on the topic of menstrual patterns among Egyptian adolescent in recent years. The aims of this study were to identify menstrual patterns and associated disorders as well as the sources of menstrual health knowledge among Egyptian adolescents.
Methods: A cross-sectional survey.
Objective: Preeclampsia (PE) is a known cause of maternal, fetal and neonatal morbidity and mortality. Thus, evaluation of the predicting value of combining the 3D assessment of placental volume with the assessment of placental perfusion indices through 3D power Doppler (3DPD) at 11-14 weeks in pregnant women at high risk to develop PE could be a suitable screening method.
Methods: 3D assessment of placental volume and 3DPD assessment of placental vascularization indices at 11-13 weeks and uterine artery Doppler scan (RI and PI) at 21-22 weeks were conducted in this prospective case-control study.